Mots-clés
 > MYOBASE > BIOLOGIE > biologie par discipline > physiologie > immunité > réponse immunitaire > autoimmunité > autoanticorps > anticorps anti-récepteur nicotinique
anticorps anti-récepteur nicotiniqueSynonyme(s)AchRab ;anti-acetylcholine receptor antibodies ;anti-acetylcholine receptor antibody ;anti-AChR Ab ;anti-AChR antibodies ;anti-AChR antibody ;anticorps anti-AChR ;anticorps anti-RACh ;anticorps anti-récepteur nicotinique à l'acétylcholine ;nicotinic cholinergic receptor antibodies ;nicotinic acetylcholine receptor antibody anti-nicotinic receptor antibodiesVoir aussi |
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de rechercheEtendre la recherche sur niveau(x) vers le bas
Correlation between myasthenia gravis-activities of daily living (MG-ADL) and quantitative myasthenia gravis (QMG) assessments of anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis in the phase 3 regain study
Vissing J, O'Brien F, Wang JJ, et al.
Muscle & Nerve, 2018
Quality of life in patients with MuSK positive myasthenia gravis
Stankovic M, Peric S, Stojiljkovic Tamas O, et al.
Acta neurologica Belgica, 2018
Thymus involvement in early-onset myasthenia gravis
Cron MA, Maillard S, Villegas J, et al.
Annals of the New York Academy of Sciences, 2018, 1412, 1, p 137
Acetylcholine receptor antibody-mediated animal models of myasthenia gravis and the role of complement
Kusner LL, Sengupta M, Kaminski HJ
Annals of the New York Academy of Sciences, 2018, 1413, 1, p 136
An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients
Villegas JA, Van Wassenhove J, Le Panse R, et al.
Annals of the New York Academy of Sciences, 2018, 1413, 1, p 154
Challenging the current model of early-onset myasthenia gravis pathogenesis in the light of the MGTX trial and histological heterogeneity of thymectomy specimens
Weis CA, Schalke B, Strobel P, et al.
Annals of the New York Academy of Sciences, 2018, 1413, 1, p 82
Serological and experimental studies in different forms of myasthenia gravis
Vincent A, Huda S, Cao M, et al.
Annals of the New York Academy of Sciences, 2018, 1413, 1, p 143
Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial)
Tackenberg B, Schneider M, Blaes F, et al.
EBiomedicine, 2018, 28, p 143
Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China
Huang X, Li Y, Feng H, et al.
Frontiers in neurology, 2018, 9
Myasthenia Gravis With Thymoma, Manifesting as AChR-Ab-Positive, Distinct Bulbar Palsy Accompanied by Dysgeusia: A Case Series and Review of Literature
Zhu K, Chen J, Li J, et al.
Frontiers in neurology, 2018, 9
Clinical features and evolution of juvenile myasthenia gravis in a French cohort
Barraud C, Desguerre I, Barnerias C, et al.
Muscle & Nerve, 2018, 57, 4, p 603
False positive acetylcholine receptor antibodies in a case of unilateral chronic progressive external ophthalmoplegia: case report and review of literature
Rajput R, Sachdev A, Din N, et al.
Orbit (Amsterdam, Netherlands), 2018, 37, 5, p 385
Myasthenia gravis: the role of complement at the neuromuscular junction
Howard JF Jr
Ann N Y Acad Sci., 2017
Ocular presentation of myasthenia gravis: A natural history cohort
Kamarajah SK, Sadalage G, Palmer J, et al.
Muscle & Nerve, 2017
Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration
Attia M, Maurer M, Robinet M, et al.
Acta neuropathologica, 2017, 134, 6, p 869
Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review
Truffault F, de Montpreville V, Eymard B, et al.
Clinical reviews in allergy & immunology, 2017, 52, 1, p 108
Multiple antibody detection in 'seronegative' myasthenia gravis patients.
Hong Y, Zisimopoulou P, Trakas N, et al.
European journal of neurology, 2017, 24, 6, p 844
Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models
Robinet M, Robinet M, Villeret B, et al.
Frontiers in immunology, 2017, 8
Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model
Sudres M, Maurer M, Robinet M, et al.
JCI insight, 2017, 2, 7
Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing
Vander Heiden JA, Stathopoulos P, Zhou JQ, et al.
Journal of immunology (Baltimore, Md. : 1950), 2017, 198, 4, p 1460
False positive immunoassay for acetyl choline receptor antibody (AChR Ab) in patients exposed to polyvalent antisnake venom
Sundar K, Venkatasubramanian S, Shanmugam S, et al.
Journal of neuroimmunology, 2017, 311, p 68
Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis
Cordts I, Bodart N, Hartmann K, et al.
Journal of neurology, 2017, 264, 6, p 1193
A retrospective study of acetylcholine receptor antibody positive ocular myasthenia in the West of Scotland
Farrugia ME, Cleary M, Carmichael C
Journal of the neurological sciences, 2017, 382, p 84
Thymectomy for myasthenia gravis: what's next?
de Perrot M, Donahoe L
Journal of thoracic disease, 2017, 9, 2, p 237
